From the Journals

Treatment priorities often differ between RA patients, clinicians

Publish date: February 21, 2018

 

FROM ARTHRITIS CARE & RESEARCH

SOURCE: Barton JL et al. Arthritis Care Res. 2018 Feb 13. doi: 10.1002/acr.23541.

Pages

Recommended Reading

Checkpoint inhibitors look safe in rheumatology patients
MDedge Rheumatology
JAK inhibitors look good for severe alopecia areata treatment
MDedge Rheumatology
Menopause accelerates RA functional decline
MDedge Rheumatology
Insights revealed into rheumatologist-patient discussions about biologics
MDedge Rheumatology
ACR sounds more welcoming tone in new biosimilars position paper
MDedge Rheumatology
‘Real-world’ study finds treat-to-target benefits out to 5 years
MDedge Rheumatology
JAK inhibitors for RA: Is VTE risk overblown?
MDedge Rheumatology
Experts review the year in rheumatology ... and what lies ahead
MDedge Rheumatology
RF-positive polyarticular JIA looks like adult RA
MDedge Rheumatology
RA associated with higher risk of psychiatric disorders
MDedge Rheumatology

Related Articles